Literature DB >> 14998502

Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.

Taro Fukao1.   

Abstract

Since the deliberate use of anthrax as a bioweapon in the USA in 2001, an enormous amount of attention has been focused on the biology of Bacillus anthracis, the causative bacterium of anthrax. Fatal systemic anthrax involves massive bacteraemia and toxaemia with non-descript early symptoms until the onset of shock and sudden death. The outbreak of fatal symptoms after the incubation period of B anthracis suggests an impairment of the host immune system against this pathogen. Thus, it is likely that B anthracis will possess certain strategies to escape from the host immune system. However, the mechanisms of such immune-evasion strategies are not fully characterised yet. Given the critical role of B anthracis toxins in anthrax pathogenesis, much effort has been made to understand the pathological nature of the toxins. Recent studies have shown the pleiotropic actions of anthrax lethal toxin on host innate immune cells, and that several effects of anthrax lethal toxin may directly account for the mechanism of immune intervention by B anthracis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998502     DOI: 10.1016/S1473-3099(04)00940-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  27 in total

1.  Antibacterial role for natural killer cells in host defense to Bacillus anthracis.

Authors:  Christine M Gonzales; Courtney B Williams; Veronica E Calderon; Matthew B Huante; Scott T Moen; Vsevolod L Popov; Wallace B Baze; Johnny W Peterson; Janice J Endsley
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

2.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

Review 3.  Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence.

Authors:  Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

4.  Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.

Authors:  Soon-Duck Ha; Chantelle Reid; Shahab Meshkibaf; Sung Ouk Kim
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

5.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Murine macrophage transcriptional responses to Bacillus anthracis infection and intoxication.

Authors:  Nicholas H Bergman; Karla D Passalacqua; Renee Gaspard; Lynne M Shetron-Rama; John Quackenbush; Philip C Hanna
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Human transferrin confers serum resistance against Bacillus anthracis.

Authors:  Suzan H M Rooijakkers; Suzanne L Rasmussen; Shauna M McGillivray; Thomas B Bartnikas; Anne B Mason; Arthur M Friedlander; Victor Nizet
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

Review 8.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

9.  Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1.

Authors:  R J Ingram; A Harris; S Ascough; G Metan; M Doganay; L Ballie; E D Williamson; H Dyson; J H Robinson; S Sriskandan; D M Altmann
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

10.  Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.

Authors:  Aimee M deCathelineau; Gary M Bokoch
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.